Jerry C. Griffin - Mar 11, 2024 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Director
Signature
/s/ Bryan Phillips, as Attorney-in-Fact for Jerry C. Griffin
Stock symbol
INSP
Transactions as of
Mar 11, 2024
Transactions value $
-$93,720
Form type
4
Date filed
3/13/2024, 09:21 PM
Previous filing
Mar 5, 2024
Next filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $16K +1K +10.76% $16.00 10.3K Mar 11, 2024 Direct F1
transaction INSP Common Stock Sale -$10.7K -54 -0.52% $198.05 10.2K Mar 11, 2024 Direct F2
transaction INSP Common Stock Sale -$99K -500 -4.88% $198.05 9.74K Mar 11, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -1K -30.34% $0.00 2.3K Mar 11, 2024 Common Stock 1K $16.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The prior Form 4 for the Reporting Person dated March 5, 2024 contained a contained a computational error in the total number of securities beneficially owned following the reported transactions. The current total reflects the accurate number of shares held by the Reporting Person.
F2 Reflects shares sold to cover taxes upon the option exercise pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F3 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F4 The option is fully vested and exercisable.